Evaluation of Steroid Therapy in COVID-19 Patients; in the Right Dose at the Right Time to the Right Patients
Authors:
Open Access
- 1 March 2023
- journal article
- research article
- Published by Medknow in Nigerian Journal of Clinical Practice
- Vol. 26 (3) , 280-286
Abstract
Background: Although there is still no universally accepted treatment agent, steroids have been administered chronologically at every dose and at every stage of the COVID-19 pandemic. Aim: We aimed to evaluate the clinical efficacy of high-dose steroid therapy and its effect on mortality in COVID-19 patients with severe pneumonia, severe Acute Respiratory Distress Syndrome (ARDS), and septic shock. Patients and Methods: Patients with severe pneumonia, septic shock, and ARDS due to COVID-19 who were followed up in the intensive care unit were retrospectively reviewed. Results: The study population was divided into two groups; the methylprednisolone pulse group (MP) (n = 55) and the dexamethasone group (Dex) (n = 39). When the values before and after treatment were compared; there was a statistically significant increase in the neutrophil/lymphocyte ratio after treatment in the MP group (p = 0.006). Although it was not statistically significant in the MP group, There was a numerical increase in D-dimer levels (p = 0.28). Thromboembolic complications developed in 2 patients in the MP group. The mortality outcomes of the groups were statistically similar (p = 0.943). Conclusion: We recommend steroids use in the condition that it is indicated in the critically ill group with the poor general condition. Since there is no significant difference between high-dose pulse steroid treatment and standard treatment doses, we think that the risk of complications should not be taken into account and high doses should not be used.Keywords
This publication has 17 references indexed in Scilit:
- Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19JAMA, 2020
- Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19JAMA, 2020
- Steroid pulse -therapy in patients With coronAvirus Pneumonia (COVID-19), sYstemic inFlammation And Risk of vEnous thRombosis and thromboembolism (WAYFARER Study)Kardiologiia, 2020
- COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?Clinical and Experimental Rheumatology, 2020
- Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injuryThe Lancet, 2020
- Acute cardiac effects of high dose steroid treatment: A speckle tracking echocardiography studyJournal of Clinical Ultrasound, 2019
- How Glucocorticoids Affect the Neutrophil LifeInternational Journal of Molecular Sciences, 2018
- Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2018
- SARS: Systematic Review of Treatment EffectsPLOS Medicine, 2006
- Cardiovascular effects of corticosteroid pulse therapy: a prospective controlled study on pemphigus patientsInternational Journal of Dermatology, 2005